Veterinary Artificial Insemination Market Share 2024-2032

According to IMARC Group’s latest research report, titled “Veterinary Artificial Insemination Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” offers a comprehensive analysis of the industry, which comprises insights into the veterinary artificial insemination market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global veterinary artificial insemination market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.37% during 2024-2032.

Veterinary Artificial Insemination Market Overview:

Veterinary artificial insemination (AI) is a reproductive technology used to artificially introduce sperm into a female animal to achieve pregnancy. This technique is widely employed in livestock management to improve breeding and enhance genetic diversity. By using AI, breeders can select high-quality genetic material from superior male animals, thereby improving herd performance in terms of growth rate, milk production, and disease resistance. The process is generally non-invasive and less stressful for the animal compared to natural mating. It is highly effective and can be performed using fresh, chilled, or frozen sperm, allowing for greater flexibility and even international exchange of genetic material. In addition to livestock like cattle, pigs, and sheep, AI is increasingly being used in equine and canine breeding programs. Veterinary AI has economic benefits, allowing farmers to maximize profitability by improving the productivity and health of their herds.

Veterinary Artificial Insemination Market Growth:

The increasing focus on livestock quality and productivity is driving the global market. Artificial insemination allows for the selective breeding of animals, contributing to improved genetics and, consequently, higher-quality meat and dairy products. Besides, continual advancements in biotechnology have led to more efficient and reliable artificial insemination techniques. These scientific improvements have made it easier for even small-scale farmers to adopt artificial insemination, thereby democratizing access to this technology and boosting its market growth. Furthermore, regulatory support also plays a role. Many governments are offering incentives and educational programs to promote the use of artificial insemination. This not only benefits individual farmers but also aims to improve the livestock industry at the national level, making it more sustainable and competitive. Moreover, it provides a standardized and consistent approach to breeding by maintaining the desired characteristics within the population and eliminating the unpredictability and variability associated with natural mating.

Competitive Landscape with Key Players:

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • ABS Global Inc. (Genus plc)
  • Agtech Inc.
  • Bovine Elite LLC
  • CRV Holding B.V.
  • IMV Technologies Inc.
  • Kruuse Ltd.
  • Neogen Corporation
  • Premier Select Sires Inc.
  • Revival Animal Health Inc.
  • Santa Cruz Biotechnology
  • Stgenetics Inc
  • Swine Genetics International Ltd
  • URUS Group LP

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global veterinary artificial insemination market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, animal type, and end user.

Breakup by Product:

  • Equipment and Consumables
  • Semen
    • Normal
    • Sexed
  • Services

Breakup by Animal Type:

  • Bovine
  • Swine
  • Ovine and Caprine
  • Equine
  • Others

Breakup by End User:

  • Veterinary Hospitals
  • Animal Husbandry
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

North America exhibits a clear dominance in the market, accounting for the largest veterinary artificial insemination market share.

Key Highlights of the Report:

  • Market Performance 
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Veterinary Artificial Insemination Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:

  • Product
  • Animal Type
  • End User
  • Region
Products Covered
  • Equipment and Consumables
  • Semen: Normal, Sexed
  • Services
Animal Types Covered Bovine, Swine, Ovine and Caprine, Equine, Others
End Users Covered Veterinary Hospitals, Animal Husbandry, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered ABS Global Inc. (Genus plc), Agtech Inc., Bovine Elite LLC, CRV Holding B.V., IMV Technologies Inc., Kruuse Ltd., Neogen Corporation, Premier Select Sires Inc., Revival Animal Health Inc., Santa Cruz Biotechnology, Stgenetics Inc, Swine Genetics International Ltd, URUS Group LP, etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163


Read More: